Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Net Sales $ 8,239 $ 16,242
Operating Expenses:        
Research and development 105,733 92,240 235,733 181,840
General and administrative (490,145) 1,352,028 4,779,429 1,970,028
Total operating expenses 384,412 (1,444,268) (5,015,162) (2,151,868)
Income / (Loss) from operations 392,651 (1,444,268) (4,998,920) (2,151,868)
Other income (expense)        
Other Income / (Expense) (6,141) (12,380)
Change in fair value of derivative liability 1,444,164 (1,180,723)
Financing costs (171,739)
Interest expense (including $58,788 and $58,788 to related parties for three months and $116,930 and $116,930 to related parties for six months) (58,788) (86,816) (262,721) (170,822)
Interest expense - amortization of debt discount (53,346) (747,623) (93,024)
Gain on debt extinguishment, net (526,871) 651,574 (552,871)
Total other expense 1,379,235 (667,033) (1,723,612) (816,717)
Net Income / (Loss) $ 1,771,886 $ (2,111,301) $ (6,722,532) $ (2,968,585)
Income / loss per share - basic and diluted $ 0.01 $ (0.02) $ (0.05) $ (0.03)
Weighted average number of common shares outstanding - basic and diluted 152,539,980 102,734,185 142,335,253 99,184,826